Orega Biotech Competitors and Similar CompaniesClear all

Orega Biotech's competitors and similar companies include VCANBIO, Spur Therapeutics and Codiak Biosciences.

	Orega Biotech Orega Biotech is a company that specializes in the discovery and development of monoclonal antibodies for cancer immunotherapy.	VCANBIO VCANBIO Cell & Gene Engineering (also known as Zhongyuan Union) is a biotech company that offers health management services and products.	Spur Therapeutics Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies.	Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
Founding Date	Founding Date 2010	Founding Date 1993	Founding Date 2015	Founding Date 2015
Type	Type Private	Type Public	Type Subsidiary	Type Public
Tags	Tags Healthcare biotech therapy	Tags Healthcare biotech medical diagnostics platform therapy	Tags Healthcare biotech therapy	Tags Healthcare biotech therapy
Locations	Locations Écully, FR HQ Montpellier, FR Montpellier, FR	Locations Tianjin, CN HQ	Locations Stevenage, GB HQ Boston, US New York, US	Locations Cambridge, US HQ
Employees	Employees 717% increase	Employees 2,0149% decrease	Employees 122	Employees 992% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) 1.4 b	Valuation ($) N/A	Valuation ($) 2.8 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥1.4b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $22.9m (FY, 2021)
Cost of goods	Cost of goods N/A	Cost of goods ¥438.8m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit ¥993.4m (FY, 2025)	Gross profit $8.9m (FY, 2022)	Gross profit N/A
Net income	Net income N/A	Net income ¥103.5m (FY, 2025)	Net income ($89m) (FY, 2022)	Net income ($37.2m) (FY, 2021)
Funding
Total funding raised	Total funding raised $ 3.7m	Total funding raised N/A	Total funding raised $ 289.3m	Total funding raised $ 168.5m